Search results for "TREATMENT"

showing 10 items of 17623 documents

Sperm chromosomal abnormalities and their contribution to human embryo aneuploidy.

2018

In this work we reviewed 18 years of experience using fluorescence in situ hybridization (FISH) for sperm aneuploidy testing. We evaluated parameters associated with increased numerical sperm chromosome abnormalities and determined the male contribution to embryo aneploidies in terms of reproductive outcome by increased sperm aneuploidy. This retrospective study analyzed data from 2008 sperm samples of infertile males undergoing FISH analysis because of clinical history of repetitive implantation failure, recurrent miscarriage, impaired sperm parameters, or mixed causes. Sperm concentration was the only sperm parameter associated with FISH results—we observed a gradual increase of abnormal …

0301 basic medicineInfertilityMaleendocrine systemmedicine.medical_treatmentAneuploidyFertilization in VitroBiologyIntracytoplasmic sperm injectionMale infertilityAndrology03 medical and health sciences0302 clinical medicinePregnancymedicineHumansSperm Injections IntracytoplasmicPrecision Medicinereproductive and urinary physiologyIn Situ Hybridization FluorescenceInfertility MalePreimplantation DiagnosisRetrospective StudiesChromosome AberrationsComparative Genomic Hybridization030219 obstetrics & reproductive medicineIn vitro fertilisationmedicine.diagnostic_testSperm Counturogenital systemHigh-Throughput Nucleotide SequencingEmbryoCell BiologyGeneral MedicineOligospermiamedicine.diseaseAneuploidySpermSpermatozoa030104 developmental biologyReproductive MedicineSperm MotilityFemaleFluorescence in situ hybridizationBiology of reproduction
researchProduct

Paving the way for a gold standard of care for infertility treatment: improving outcomes through standardization of laboratory procedures.

2016

Infertility affects over 70 million couples globally. Access to, and interest in, assisted reproductive technologies is growing worldwide, with more couples seeking medical intervention to conceive, in particular by IVF. Despite numerous advances in IVF techniques since its first success in 1978, almost half of the patients treated remain childless. The multifactorial nature of IVF treatment means that success is dependent on many variables. Therefore, it is important to examine how each variable can be optimized to achieve the best possible outcomes for patients. The current approach to IVF is fragmented, with various protocols in use. A systematic approach to establishing optimum best pra…

0301 basic medicineInfertilityMalemedicine.medical_specialtyStandardizationReproductive Techniques AssistedBest practiceReproductive technology03 medical and health sciencesEndometrium0302 clinical medicineIntervention (counseling)medicineHumansIntensive care medicineBirth RateInfertility MalePreimplantation DiagnosisGynecologyIvf treatment030219 obstetrics & reproductive medicinebusiness.industryClinical Laboratory TechniquesGold standardObstetrics and GynecologyStandard of Caremedicine.diseaseCulture Media030104 developmental biologyTreatment OutcomeReproductive MedicineFemalebusinessLive birthInfertility FemaleDevelopmental BiologyReproductive biomedicine online
researchProduct

Phytochemical inhibitors of the NLRP3 inflammasome for the treatment of inflammatory diseases

2021

The NLRP3 inflammasome holds a crucial role in innate immune responses. Pathogen- and danger-associated molecular patterns may initiate inflammasome activation and following inflammatory cytokine release. The inflammasome formation and its-associated activity are involved in various pathological conditions such as cardiovascular, central nervous system, metabolic, renal, inflammatory and autoimmune diseases. Although the mechanism behind NLRP3-mediated disorders have not been entirely illuminated, many phytochemicals and medicinal plants have been described to prevent inflammatory disorders. In the present review, we mainly introduced phytochemicals inhibiting NLRP3 inflammasome in addition…

0301 basic medicineInflammasomesmedicine.medical_treatmentPhytochemicalsAnti-Inflammatory AgentsInflammation03 medical and health sciences0302 clinical medicineNLR Family Pyrin Domain-Containing 3 ProteinmedicineAnimalsHumansInflammationPharmacologyInnate immune systemintegumentary systembusiness.industryMechanism (biology)Inflammasome030104 developmental biologyCytokinePhytochemical030220 oncology & carcinogenesisImmunologyNLRP3 inflammasome activationInflammation Mediatorsmedicine.symptomSignal transductionbusinessSignal Transductionmedicine.drugPharmacological Research
researchProduct

2018

The catabolic process of autophagy plays important functions in inflammatory and immune responses by modulating innate immunity and adaptive immunity. Over the last decade, a cell-intrinsic role for autophagy in modulating CD4 T cell functions and differentiation was revealed. After the initial observation of autophagosomes in effector CD4 T cells, further work has shown that not only autophagy levels are modulated in CD4 T cells in response to environmental signals but also that autophagy critically affects the biology of these cells. Mouse models of autophagy deletion in CD4 T cells have indeed shown that autophagy is essential for CD4 T cell survival and homeostasis in peripheral lymphoi…

0301 basic medicineInnate immune systemmedicine.medical_treatmentT cellImmunologyCellAutophagyImmunotherapyBiologyAcquired immune systemT-Cell Receptor Activation3. Good healthCell biology03 medical and health sciences030104 developmental biologymedicine.anatomical_structureImmune systemmedicineImmunology and AllergyFrontiers in Immunology
researchProduct

Interleukin-2 Functionalized Nanocapsules for T Cell-Based Immunotherapy.

2016

A major demand on immunotherapy is the direct interference with specific immune cells in vivo. In contrast to antibody-engineered nanoparticles to control dendritic cells function, targeting of T cells for biomedical applications still remains an obstacle as they disclose reduced endocytic activities. Here, by coupling the cytokine interleukin-2 (IL-2) to the surface of hydroxyethyl starch nanocapsules, we demonstrated a direct and specifc T cell targeting in vitro and in vivo by IL-2 receptor-mediated internalization. For this purpose, defined amounts of azide-functionalized IL-2 were linked to alkyne-functionalized hydroxyethyl starch nanocapsules via copper-free click reactions. In combi…

0301 basic medicineInterleukin 2Materials sciencemedicine.medical_treatmentT cellmedia_common.quotation_subjectGeneral Physics and Astronomy02 engineering and technologyNanocapsules03 medical and health sciencesImmune systemIn vivomedicineGeneral Materials ScienceInternalizationmedia_commonGeneral EngineeringImmunotherapy021001 nanoscience & nanotechnologyCell biology030104 developmental biologyCytokinemedicine.anatomical_structureImmunology0210 nano-technologymedicine.drug
researchProduct

Targeted Activation of T Cells with IL-2-Coupled Nanoparticles

2020

Interleukin-2 (IL-2) is a T cell growth factor particularly required in regulatory T cell maintenance and memory T cell responses. High-dose IL-2 treatment was the first FDA-approved immunotherapy for cancer, while low-dose IL-2 administration has shown promise in allograft rejection and autoimmune and inflammatory diseases. However, its pleiotropic nature and the existence of IL-2 receptors with different binding affinity limit its therapeutic application. For an improved clinical applicability of the cytokine, a targeted receptor assignment must, therefore, be achieved. Nanoparticles allow controlling the location and dose of immunomodulating compounds and to specifically address specific…

0301 basic medicineInterleukin 2Regulatory T cellT-Lymphocytesmedicine.medical_treatmentT cellReviewmedicine.disease_causeAutoimmunity03 medical and health sciences0302 clinical medicinemedicineHumansReceptorlcsh:QH301-705.5General MedicineImmunotherapy030104 developmental biologymedicine.anatomical_structureCytokinelcsh:Biology (General)030220 oncology & carcinogenesisCancer researchinterleukin-2nanoparticlesimmunotherapyMemory T cellmedicine.drugCells
researchProduct

Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion

2015

Activation of TNFR2 with a novel agonist expands T reg cells in vivo and protects allo-HCT recipients from acute GvHD while sparing antilymphoma and antiinfectious properties of transplanted donor T cells.

0301 basic medicineInterleukin 2medicine.medical_treatmentImmunologyGraft vs Host DiseaseMice Inbred Strainschemical and pharmacologic phenomenaHematopoietic stem cell transplantationBiologyT-Lymphocytes RegulatoryArticleMice03 medical and health sciencesInterleukin 21immune system diseaseshemic and lymphatic diseasesmedicineAnimalsReceptors Tumor Necrosis Factor Type IIImmunology and AllergyCytotoxic T cellddc:610Research Articlesintegumentary systemMyeloid-Derived Suppressor CellsHematopoietic Stem Cell TransplantationFOXP3hemic and immune systemsmedicine.diseaseLeukemiaddc:57030104 developmental biologysurgical procedures operativeAcute DiseaseImmunologyMyeloid-derived Suppressor CellInterleukin-2FemaleTumor necrosis factor receptor 2medicine.drug
researchProduct

Redox Status, Dose and Antioxidant Intake in Healthcare Workers Occupationally Exposed to Ionizing Radiation

2020

The purpose of this study was to evaluate the relationship between blood redox status, dose and antioxidant dietary intake of different hospital staff groups exposed to low doses of ionizing radiation (LDIR) (Interventional Radiology and Cardiology, Radiation Oncology, and Nuclear Medicine) and non-exposed. Personal dose equivalent (from last year and cumulative), plasma antioxidant markers (total antioxidant capacity, extracellular superoxide dismutase activity, and glutathione/oxidized glutathione ratio), oxidative stress markers (nitrites and nitrates, and lipid peroxidation) and dietary intake (antioxidant capacity using ORAC values) were collected and analyzed from 28 non-exposed healt…

0301 basic medicineIonizing radiationAntioxidantPhysiologyThiobarbituric acidmedicine.medical_treatmentClinical BiochemistryPhysiologymedicine.disease_causeBiochemistryArticleIonizing radiationLipid peroxidation03 medical and health scienceschemistry.chemical_compound0302 clinical medicineOxygen radical absorbance capacity (ORAC)TBARSMedicineMolecular Biologypersonal dose equivalentPersonal dose equivalentbusiness.industryEquivalent doselcsh:RM1-950Antioxidant-oxidant statusCell BiologyGlutathioneoccupational exposureOccupational exposure030104 developmental biologyantioxidant-oxidant statuslcsh:Therapeutics. Pharmacologychemistryoxygen radical absorbance capacity (ORAC)030220 oncology & carcinogenesisbusinessionizing radiationOxidative stressAntioxidants
researchProduct

Update of the therapeutic planning of irrigation and intracanal medication in root canal treatment. A literature review

2019

Background The success of endodontic treatment derives from the complete elimination of microorganisms capable of causing an intraradicular or extraradicular infection. To achieve a more effective eradication of these microorganisms, endodontic instrumentation must always be implemented with abundant irrigation, which has to achieve chemical, mechanical and biological effects. The irrigators most used today are NaOCl, CHX and EDTA, released into the ducts through different techniques such as syringe, manual agitation, positive or negative apical pressure, sonic or ultrasonic activation, PIPS and PDT. The objective of this review is to update the different irrigating solutions and intracanal…

0301 basic medicineIrrigationRoot canalDentistryOdontologíaReviewAntibacterial effectOperative Dentistry and Endodontics03 medical and health sciences0302 clinical medicineEnterococcus faecalismedicineEndodonciaGeneral DentistryEndodontic retreatmentInfeccionesbusiness.industryAntimicrobial efficacy030206 dentistry:CIENCIAS MÉDICAS [UNESCO]030104 developmental biologymedicine.anatomical_structureUNESCO::CIENCIAS MÉDICASIRRIGATING SOLUTIONSbusinessSystematic searchJournal of Clinical and Experimental Dentistry
researchProduct

CD1A-positive cells and HSP60 (HSPD1) levels in keratoacanthoma and squamous cell carcinoma.

2015

CD1a is involved in presentation to the immune system of lipid antigen derived from tumor cells with subsequent T cell activation. Hsp60 is a molecular chaperone implicated in carcinogenesis by, for instance, modulating the immune reaction against the tumor. We have previously postulated a synergism between CD1a and Hsp60 as a key factor in the activation of an effective antitumor immune response in squamous epithelia. Keratoacantomas (KAs) are benign tumors that however can transform into squamous cell carcinomas (SCCs), but the reasons for this malignization are unknown. In a previous study, we found that CD1a-positive cells are significantly more numerous in KA than in SCC. In this study…

0301 basic medicineKeratoacanthomaCellmedicine.disease_causeBiochemistryAntigens CD10302 clinical medicineSquamous cell carcinomaAged 80 and overintegumentary systemPrognostic evaluationMiddle AgedHsp60ImmunohistochemistryKeratoacanthomamedicine.anatomical_structure030220 oncology & carcinogenesisCarcinoma Squamous CellImmunohistochemistryHSP60AdultT cellDifferential diagnosichemical and pharmacologic phenomenaCD1aBiologySettore MED/08 - Anatomia PatologicaDiagnosis DifferentialMitochondrial Proteins03 medical and health sciencesYoung AdultKeratoacantomaImmune systemmedicineBiomarkers TumorHumansAgedRetrospective StudiesOriginal PaperSettore BIO/16 - Anatomia UmanaCD1a; Differential diagnosis; Hsp60; Immunohistochemistry; Keratoacantoma; Prognostic evaluation; Squamous cell carcinoma; Treatment; Biochemistry; Cell BiologyfungiCell BiologyChaperonin 60medicine.diseaseTreatmentstomatognathic diseases030104 developmental biologyCancer researchDifferential diagnosisCarcinogenesisCell stresschaperones
researchProduct